BY | November 17, 2012

Taipei, (IANS) A research team has found the prevalence of common mental disorders (CMDs) in Taiwan has doubled over the last two decades, Xinhua reported.

Researchers at Taiwan’s institute of biomedical sciences analysed data from 9,079 respondents, found the prevalence of CMDs rose from 11.5 percent in 1990 to 23.8 percent in 2010, according to a press release issued by Taiwan’s “Academia Sinica”.

It said the common mental disorders are a broad diagnostic category of non-psychotic depressive and anxiety disorders that account for over 90 percent of all mental disorders.

Being female, unemployed or underemployed, unmarried and under-educated present increased risk factors for developing CMDs. It has also been proposed that economic instability and income inequality may increase the risk for mental disorders, the release added.

The study, published online earlier this week in the world’s leading general medical journal — The Lancet — found that the increased prevalence of CMDs coincided with rises in unemployment, divorce and suicide rates in Taiwan over the same study period.

The study suggests that the significant trend in the increase in rates of CMDs may be at least partly due to macro-social changes, including the continued decline in the employment market and the ongoing global economic recession.

Andrew Tai-Ann Cheng, the study leader, said the research not only highlighted the need to implement effective clinical and social preventative measures to promote mental health, but also the effects of uncertainty on mental health.

A sense of insecurity, much like that seen in response to losing a job, can negatively impact mental health, he added.

RELATED

Anxiety following false-positive mammogram results end early   For every person this is like bad dream. A positive mammogram result may be a bad news for anyone among us. And the same impact is made on the person if a false positive result is given to him in case of...

Roche’s breast cancer drug Kadcyla price far too high There is no denying the fact that Roche’s Kadcyla is a very effective breast cancer drug. Its positive impacts on the patients suffering from breast cancer have been praised by doctors and experts across the...

Internet connects retirees with others, saves from depression   Loneliness is the biggest and the most depressing aspect of elderly people’s life. As they age, the number of people they interact with starts going down and in many cases most people are not left with...

aanty-devi

Malignant melanoma rises five times since 70s     More and more people are being diagnosed of malignant melanoma these days. In 1970, their numbers were five times less than what it is today, according to experts. But the silver lining in the dark cloud is...

cancer-cell

Infertility treatment in focus   Is your state “fertility friendly”? This and others questions are being debated on the National Infertility Week. Its importance is being felt at a time when the National Infertility Association has released its annual Fertility...

Sarepta’s Duchenne muscular dystrophy (DMD) drug Eteplirsen gets lifeline by FDA   Sarepta Therapeutics Inc's shares jumped to a record high as the US Food and Drug Administration (FDA) showed its preparedness to approve its experimental muscle disorder...